Evidence map›Paper›PMID 35699949›Full record

ArticleDiabetes care2022

Brain Structure Among Middle-aged and Older Adults With Long-standing Type 1 Diabetes in the DCCT/EDIC Study.

Alan M Jacobson, Barbara H Braffett, Guray Erus, Christopher M Ryan, Geert J Biessels, José A Luchsinger, Ionut Bebu, Rose A Gubitosi-Klug, Lisa Desiderio, Gayle M Lorenzi and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Thalamic Nuclei Atrophy in Type 1 Diabetes Mellitus Across Disease Duration.Journal of magnetic resonance imaging : JMRI · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Metabolic memory: mechanisms and diseases.Signal transduction and targeted therapy · 2024
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 2 countries.

Alan M JacobsonNYU Long Island School of Medicine, NYU Langone Hospital-Long Island, Mineola.
Barbara H BraffettThe Biostatistics Center, The George Washington University, Rockville, MD.ORCID 0000-0002-2184-9754
Guray ErusDepartment of Radiology, University of Pennsylvania, Philadelphia, PA.
Christopher M RyanUniversity of Pittsburgh, Pittsburgh, PA.
Geert J BiesselsDepartment of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Netherlands.ORCID 0000-0001-6862-2496
José A LuchsingerColumbia University Irving Medical Center, New York, NY.
Ionut BebuThe Biostatistics Center, The George Washington University, Rockville, MD.ORCID 0000-0002-4944-7968
Rose A Gubitosi-KlugCase Western Reserve University School of Medicine, Rainbow Babies & Children's Hospital, Cleveland, OH.ORCID 0000-0002-7376-6870
Lisa DesiderioDepartment of Radiology, University of Pennsylvania, Philadelphia, PA.
Gayle M LorenziUniversity of California San Diego, La Jolla, CA.
Victoria R TrapaniDepartment of Radiology, University of Pennsylvania, Philadelphia, PA.
John M LachinDepartment of Radiology, University of Pennsylvania, Philadelphia, PA.ORCID 0000-0001-9838-2841
R Nick BryanThe University of Texas at Austin, Austin, TX.
Mohamad HabesNeuroimage Analytics Laboratory and Biggs Institute Neuroimaging Core, Glenn Biggs Institute for Neurodegenerative Disorders, University of Texas Health Science Center at San Antonio, San Antonio, TX.
Ilya M NasrallahDepartment of Radiology, University of Pennsylvania, Philadelphia, PA.
DCCT/EDIC Research Group
University of Pennsylvania · USGeorge Washington University · USColumbia University Irving Medical Center · USIsland Hospital · USRainbow Babies & Children's Hospital · USThe University of Texas at Austin · USThe University of Texas Health Science Center at San Antonio · USUniversity Medical Center Utrecht · NLUniversity of California San Diego · USUniversity of Pittsburgh · US

Funding

Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Clinical Research Center (Collaborative U01)U01DK094157 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI Ionut Bebu, Barbara Halina Braffett · 2011 to 2026
$97.6M
Epidemiology of Diabetes Interventions and Complications Data Coordinating CenterU01DK094176 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI BEBU, IONUT, BRAFFETT, BARBARA HALINA · 2012 to 2022
$30.8M
New York Regional Center for Diabetes Translation Research - Translational Intervention Methodology CoreP30DK111022 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY GONZALEZ · 2016 to 2026
$7.8M
Effects of Biomedical Risk Factors on Neuro-cognition Using MRI: Long term follow-up of the Diabetes Control & Complications Trial/Epidemiology of Diabetes Interventions and Complications Study CohortDP3DK114812 · NIDDK · NYU WINTHROP HOSPITAL · PI JACOBSON, ALAN M · 2017 to 2019
$4.7M
NIDDK NIH HHS DP3 DK114812NIDDK NIH HHS P30 DK111022NIDDK NIH HHS U01 DK094157NIDDK NIH HHS U01 DK094176
6 · The paper itself

Abstract

objectiveIndividuals with type 1 diabetes mellitus (T1DM) are living to ages when neuropathological changes are increasingly evident. We hypothesized that middle-aged and older adults with long-standing T1DM will show abnormal brain structure in comparison with control subjects without diabetes. RESEARCH DESIGN AND

methodsMRI was used to compare brain structure among 416 T1DM participants in the Epidemiology of Diabetes Interventions and Complications (EDIC) study with that of 99 demographically similar control subjects without diabetes at 26 U.S. and Canadian sites. Assessments included total brain (TBV) (primary outcome), gray matter (GMV), white matter (WMV), ventricle, and white matter hyperintensity (WMH) volumes and total white matter mean fractional anisotropy (FA). Biomedical assessments included HbA1c and lipid levels, blood pressure, and cognitive assessments of memory and psychomotor and mental efficiency (PME). Among EDIC participants, HbA1c, severe hypoglycemia history, and vascular complications were measured longitudinally.

resultsMean age of EDIC participants and control subjects was 60 years. T1DM participants showed significantly smaller TBV (least squares mean ± SE 1,206 ± 1.7 vs. 1,229 ± 3.5 cm3, P < 0.0001), GMV, and WMV and greater ventricle and WMH volumes but no differences in total white matter mean FA versus control subjects. Structural MRI measures in T1DM were equivalent to those of control subjects who were 4-9 years older. Lower PME scores were associated with altered brain structure on all MRI measures in T1DM participants.

conclusionsMiddle-aged and older adults with T1DM showed brain volume loss and increased vascular injury in comparison with control subjects without diabetes, equivalent to 4-9 years of brain aging.

Indexed as

Diabetes ComplicationsDiabetes Mellitus, Type 1AgedBrainCanadaGlycated HemoglobinHumansMiddle AgedRisk FactorsGlycated Hemoglobin

Identifiers

PMID35699949
PMCPMC9346989
OpenAlexW4282843246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.